UnratedDrug recall · FDA · Published June 13, 2023
AVKARE Tranexamic Acid Tablets Recall: Impurities May Cause Safety Issues
AVKARE recalls Tranexamic Acid 650mg tablets (NDC 50268-772-13) due to impurities. This recall affects prescription-only units manufactured in Pulaski, TN. No specific action is required per official notice.
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Take action
Contact the company
📍Recalling firmAVKARE LLC615 N 1st St · Pulaski, TN 38478-2403
✎ GovInfoNow plain-language explainer
AVKARE is recalling Tranexamic Acid USP tablets (650 mg, 30 tablets) because testing found impurities that may affect safety. This recall applies to prescription-only units manufactured in Pulaski, TN. Since no remedy is specified, users should check with their doctor if they have these tablets. Read more at govinfonow.com/recall/33409-avkare-tranexamic-acid-tablets-recall-impurities-may-cause-safety-issues.
“AVKARE Tranexamic Acid Tablets Recall: Impurities May Cause Safety Issues.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33409-avkare-tranexamic-acid-tablets-recall-impurities-may-cause-safety-issues. Based on FDA recall #D-0875-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0875-2023%22&limit=1).
The FDA announced on June 13, 2023, that AVKARE LLC voluntarily recalled Tranexamic Acid USP Tablets due to failed impurity specifications. The agency issued recall number D-0875-2023 for the Class III product distributed nationwide.
The recall addresses out-of-specification results obtained for conductivity in the Tranexamic Acid USP Tablets. The FDA classified this as a Class III recall involving failed impurities and degradation specifications.
Context
GovInfoNow's records show AVKARE LLC has two other recalls on file since December 22, 2022. On August 11, 2023, the company recalled Sodium Fluoride Toothpaste due to wrong labeling risks involving Capsaicin Cream cartons. Other recent recalls of similar products include Alembic Fesoterodine Tablets Recall (December 16, 2025), Sun Pharmaceutical Fexofenadine 180mg Tablets Recall (June 1, 2026), and Somerset Therapeutics Dexamethasone Injection Recall (February 4, 2026).
How to tell if you have this one
Look for Tranexamic Acid USP tablets labeled 650 mg, 30 tablets (3X10), with NDC 50268-772-13. These were manufactured in Pulaski, TN and expire February 2025.
Brand
AVKARE
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Medication
Verify if your prescription contains Tranexamic Acid USP tablets with NDC 50268-772-13 manufactured in Pulaski, TN.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 8 days after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0875-2023 (June 13, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0875-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.